PEOPLE - Hypoguard makes appointment:
This article was originally published in Clinica
Executive Summary
Blood glucose monitoring systems, sharps safety devices and urine testing equipment producer Hypoguard (Minneapolis, Minnesota) has appointed former Akubio CEO John Pritchard as CSO, in which role he will lead the company's technology strategy and oversee R&D worldwide. Based at Suffolk, UK, he will also lead new technology acquisition and licensing tactics. Dr Pritchard has also served as VP of R&D at Genzyme's diagnostics division, and ran development of the first generation Boehringer Mannheim/Roche AccuChek Advantage biosensor strip.